IL293541A - Ophthalmic preparations - Google Patents
Ophthalmic preparationsInfo
- Publication number
- IL293541A IL293541A IL293541A IL29354122A IL293541A IL 293541 A IL293541 A IL 293541A IL 293541 A IL293541 A IL 293541A IL 29354122 A IL29354122 A IL 29354122A IL 293541 A IL293541 A IL 293541A
- Authority
- IL
- Israel
- Prior art keywords
- composition
- months
- ophthalmic
- formula
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944074P | 2019-12-05 | 2019-12-05 | |
| US202063077196P | 2020-09-11 | 2020-09-11 | |
| PCT/US2020/063218 WO2021113580A1 (en) | 2019-12-05 | 2020-12-04 | Ophthalmic pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL293541A true IL293541A (en) | 2022-08-01 |
Family
ID=74104179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL293541A IL293541A (en) | 2019-12-05 | 2020-12-04 | Ophthalmic preparations |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230026577A1 (https=) |
| EP (1) | EP4069195A1 (https=) |
| JP (2) | JP7833399B2 (https=) |
| KR (1) | KR20220128619A (https=) |
| CN (1) | CN115397392A (https=) |
| AU (1) | AU2020398224B2 (https=) |
| BR (1) | BR112022010871A2 (https=) |
| CA (1) | CA3160484A1 (https=) |
| CL (1) | CL2022001463A1 (https=) |
| CO (1) | CO2022009260A2 (https=) |
| IL (1) | IL293541A (https=) |
| MX (1) | MX2022006776A (https=) |
| TW (1) | TWI845795B (https=) |
| WO (1) | WO2021113580A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL300628A (en) * | 2020-09-10 | 2023-04-01 | Vanda Pharmaceuticals Inc | Methods for the treatment of cyclic diseases or conditions-PDE IV |
| HU231668B1 (hu) * | 2021-12-28 | 2025-06-28 | Semmelweis Egyetem 60% | Szemcsepp készítmény |
| US20250073125A1 (en) * | 2023-09-06 | 2025-03-06 | Opus Life Sciences, Llc | High ph formulations and kits |
| WO2025179141A1 (en) | 2024-02-22 | 2025-08-28 | Vanda Pharmaceuticals, Inc. | Treatment of dry eye disease |
| KR20260048121A (ko) * | 2024-10-02 | 2026-04-09 | 주식회사 대웅테라퓨틱스 | 개선된 안정성 및 투약 편의성을 갖는 레바미피드를 포함하는 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1321144T3 (da) * | 2000-09-13 | 2011-03-07 | Santen Pharmaceutical Co Ltd | Øjendråber |
| CN101537172B (zh) | 2008-08-14 | 2010-06-30 | 温州医学院 | 一种含有重组人角质细胞生长因子-2滴眼液及其制备方法 |
| CN101690712B (zh) | 2009-08-25 | 2011-06-15 | 武汉武药科技有限公司 | 一种西他沙星滴眼剂及其制备方法 |
| US20110178147A1 (en) | 2009-10-20 | 2011-07-21 | Allergan, Inc. | Compositions and methods for controlling pupil dilation |
| FR2961694B1 (fr) | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| CN102988280B (zh) | 2012-10-08 | 2014-03-19 | 新乡医学院 | 一种加雷沙星滴眼剂 |
| CN109481392B (zh) * | 2015-09-02 | 2021-12-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种用于预防和治疗白内障的眼用制剂及其制备方法 |
| WO2017083799A1 (en) * | 2015-11-13 | 2017-05-18 | Ohr Pharmaceutical, Inc. | Ophthalmic formulations of squalamine |
| MX383072B (es) * | 2015-12-24 | 2025-03-13 | Univ California | Reguladores del cftr y métodos para su uso |
| US20180236077A1 (en) | 2017-02-21 | 2018-08-23 | Avedro, Inc. | Formulations for eye treatments |
| JP2020531511A (ja) | 2017-08-24 | 2020-11-05 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | 眼球用医薬組成物 |
-
2020
- 2020-12-04 BR BR112022010871A patent/BR112022010871A2/pt unknown
- 2020-12-04 JP JP2022533510A patent/JP7833399B2/ja active Active
- 2020-12-04 CN CN202080094414.9A patent/CN115397392A/zh active Pending
- 2020-12-04 AU AU2020398224A patent/AU2020398224B2/en active Active
- 2020-12-04 KR KR1020227022823A patent/KR20220128619A/ko active Pending
- 2020-12-04 EP EP20830416.2A patent/EP4069195A1/en active Pending
- 2020-12-04 US US17/782,197 patent/US20230026577A1/en active Pending
- 2020-12-04 IL IL293541A patent/IL293541A/en unknown
- 2020-12-04 MX MX2022006776A patent/MX2022006776A/es unknown
- 2020-12-04 CA CA3160484A patent/CA3160484A1/en active Pending
- 2020-12-04 WO PCT/US2020/063218 patent/WO2021113580A1/en not_active Ceased
- 2020-12-04 TW TW109142969A patent/TWI845795B/zh active
-
2022
- 2022-06-02 CL CL2022001463A patent/CL2022001463A1/es unknown
- 2022-07-01 CO CONC2022/0009260A patent/CO2022009260A2/es unknown
-
2025
- 2025-07-14 JP JP2025117830A patent/JP2025160247A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220128619A (ko) | 2022-09-21 |
| TWI845795B (zh) | 2024-06-21 |
| AU2020398224A1 (en) | 2022-06-30 |
| AU2020398224B2 (en) | 2026-02-19 |
| JP7833399B2 (ja) | 2026-03-19 |
| JP2025160247A (ja) | 2025-10-22 |
| WO2021113580A1 (en) | 2021-06-10 |
| CA3160484A1 (en) | 2021-06-10 |
| CN115397392A (zh) | 2022-11-25 |
| CO2022009260A2 (es) | 2022-09-20 |
| JP2023505255A (ja) | 2023-02-08 |
| TW202128178A (zh) | 2021-08-01 |
| BR112022010871A2 (pt) | 2022-08-23 |
| EP4069195A1 (en) | 2022-10-12 |
| MX2022006776A (es) | 2022-09-19 |
| US20230026577A1 (en) | 2023-01-26 |
| CL2022001463A1 (es) | 2023-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020398224B2 (en) | Ophthalmic pharmaceutical compositions | |
| EP2278953B1 (en) | Self-preserved emulsions | |
| US20100120908A1 (en) | Eye drop preparation comprising latanoprost | |
| US9456980B2 (en) | Latanoprost-containing aqueous pharmaceutical composition | |
| CN108883064B (zh) | 包含pvp-i的眼用组合物 | |
| CN1750818A (zh) | 注射用扑热息痛液态制剂 | |
| KR20250024925A (ko) | 수성 티카그렐러 용액, 제조 방법 및 용도 | |
| US9561280B2 (en) | Aqueous liquid bromfenac composition having preservative efficacy | |
| JP2010204597A (ja) | ソフトコンタクトレンズ用組成物及びソフトコンタクトレンズへの吸着抑制方法 | |
| WO2014204952A1 (en) | Stable bromfenac solution | |
| RU2832581C1 (ru) | Офтальмологические фармацевтические композиции | |
| TW201801719A (zh) | 眼科用製品及黏度降低抑制方法 | |
| US20170000889A1 (en) | Stable bromfenac ophthalmic solution | |
| US7259185B2 (en) | Stable warfarin sodium liquid formulation and method of making same | |
| EP4595959A1 (en) | Sterilized heterocyclidene-acetamide-derivative-containing suspension | |
| BR122024022133A2 (pt) | Composições farmacêuticas oftalmológicas e uso das mesmas | |
| US11229597B2 (en) | Topical doxycycline composition | |
| JP2009079032A (ja) | 眼科用組成物及びジフェンヒドラミンの安定化方法 | |
| CA3054374A1 (en) | Composition for intravesical administration for treating bladder pain | |
| EA049828B1 (ru) | Офтальмологический раствор | |
| GR1010821B (el) | Σταθερο ομογενοποιημενο φαρμακευτικο ρινικο εναιωρημα συνδυασμου αζελαστινης και φλουτικαζονης | |
| EA042509B1 (ru) | Офтальмологическое дозирующее устройство |